In a patient with mild normocytic anemia (low hemoglobin and hematocrit, normal MCV, borderline low MCHC) and normal white blood cell count, is this iron‑deficiency anemia and should iron and ferritin supplementation be initiated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This is NOT iron deficiency anemia, and iron supplementation should NOT be initiated without further diagnostic workup

Based on the laboratory values provided, this patient has mild normocytic anemia (normal MCV 92.4 fL) with borderline low MCHC, which does NOT meet diagnostic criteria for iron deficiency anemia. The diagnosis of iron deficiency requires measurement of serum ferritin and/or transferrin saturation, which are completely absent from this workup 1, 2.

Critical Missing Laboratory Tests

You cannot diagnose or exclude iron deficiency without:

  • Serum ferritin (the most powerful test for iron deficiency) 3, 1
  • Transferrin saturation (alternative or complementary diagnostic marker) 4

Serum ferritin <30 μg/L in the absence of inflammation is diagnostic of iron deficiency 5, 1, 6, 2. In the presence of inflammation (elevated CRP), ferritin up to 100 μg/L may still indicate iron deficiency 7, 5, 6.

Why This Presentation is NOT Classic Iron Deficiency Anemia

The MCV is Normal (92.4 fL)

  • Iron deficiency anemia typically presents with microcytosis (low MCV) 3, 1
  • Normocytic anemia suggests alternative etiologies:
    • Anemia of chronic disease (most common with normal MCV) 7, 6
    • Combined deficiencies (iron + B12/folate, which can mask each other) 3, 6
    • Early iron deficiency (before microcytosis develops)
    • Chronic kidney disease
    • Hemolysis
    • Bone marrow disorders

The Pattern Suggests Further Investigation is Needed

The combination of:

  • Low hemoglobin (10.6 g/dL, below 11.7 g/dL threshold for women) 1
  • Low hematocrit (34.0%, below 35.9%)
  • Normal MCV (92.4 fL)
  • Borderline low MCHC (31.2 g/dL)
  • Normal RDW (13.3%)

This pattern is inconsistent with typical iron deficiency anemia, which would show microcytosis and often elevated RDW 3, 1, 6.

Algorithmic Approach to This Patient

Step 1: Order Iron Studies Immediately

  • Serum ferritin (most specific test) 1, 2
  • Transferrin saturation (iron/TIBC × 100) 4
  • CRP or ESR (to assess for inflammation that affects ferritin interpretation) 7, 5

Step 2: Interpret Based on Inflammation Status

If NO inflammation (normal CRP/ESR):

  • Ferritin <15 μg/L = absolute iron deficiency 3, 1
  • Ferritin <30 μg/L = iron deficiency 5, 1, 6, 2
  • Transferrin saturation <16-20% = iron deficiency 7, 5, 4

If inflammation present (elevated CRP/ESR):

  • Ferritin <30 μg/L = iron deficiency 7, 5
  • Ferritin 30-100 μg/L + transferrin saturation <16-20% = likely combined iron deficiency and anemia of chronic disease 7, 5, 6
  • Ferritin >100 μg/L + transferrin saturation <16-20% = anemia of chronic disease 7, 5
  • Ferritin >100 μg/L makes iron deficiency unlikely 3, 1

Step 3: Consider Additional Workup for Normocytic Anemia

  • Reticulocyte count (to assess bone marrow response) 6
  • Vitamin B12 and folate (combined deficiency can normalize MCV) 3, 6
  • Renal function (creatinine, BUN for chronic kidney disease)
  • Thyroid function if clinically indicated
  • Hemolysis markers if reticulocyte count elevated (haptoglobin, LDH, bilirubin) 6

Step 4: Treatment Decision Tree

DO NOT start iron supplementation empirically without confirming iron deficiency 1, 2.

If iron deficiency confirmed:

  • Oral iron (ferrous sulfate 325 mg daily or alternate days) is first-line 8
  • Recheck hemoglobin in 4 weeks (expect ≥1 g/dL increase if iron deficiency) 9, 10
  • Continue for 2-3 months after hemoglobin normalizes to replete stores 9

If anemia of chronic disease:

  • Treat underlying inflammatory condition 7
  • Consider IV iron if transferrin saturation <20% and ferritin 30-100 μg/L 7, 5

If combined deficiency:

  • Address both iron and other nutritional deficiencies 6

Common Pitfalls to Avoid

  1. Starting iron without ferritin measurement – This is the most common error. You cannot diagnose iron deficiency from CBC alone when MCV is normal 1, 2.

  2. Assuming normocytic anemia excludes iron deficiency – While microcytosis is typical, early iron deficiency or combined deficiencies can present with normal MCV 3, 6.

  3. Ignoring inflammation status – Ferritin is an acute phase reactant; interpretation requires knowing inflammatory status 7, 5, 1.

  4. Using ferritin <15 μg/L as the only threshold – Current guidelines support ferritin <30 μg/L (without inflammation) as diagnostic 5, 1, 6, 2.

  5. Not investigating the cause – In adults, iron deficiency anemia requires investigation for gastrointestinal blood loss, malabsorption, or other underlying pathology 3, 1.

Bottom Line

Order serum ferritin, transferrin saturation, and inflammatory markers before making any treatment decisions. The current laboratory data are insufficient to diagnose iron deficiency anemia, and empiric iron supplementation without proper diagnosis risks missing alternative or coexisting conditions that require different management 1, 2, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.